JPMorgan raised the firm’s price target on Eaton to $279 from $255 and keeps an Overweight rating on the shares. The analyst increased price targets in the multi-industry group following the Q4 reports. The environment remains divergent, dominated by strong demand from data center, grid, energy to a degree, and U.S. mega projects, and non-residential construction “defying the bears and still growing,” with other markets in total continuing to show negative volumes, the analyst tells investors in a research note. The firm says that while destocking pressures remain, most believe they are close to the end of this process.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ETN:
- Eaton price target raised to $250 from $220 at Barclays
- Eaton price target raised to $246 from $220 at RBC Capital
- Correction: Eton Pharmaceuticals announces availability of Nitisinone Capsules
- Eaton announces availability of Nitisinone Capsules
- Eaton price target raised to $300 from $260 at Mizuho
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue